The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy
Keli Lima(Universidade de São Paulo), João Agostinho Machado‐Neto(Universidade de São Paulo)
Cited by 29
Related Papers
Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms
|Cell Death and Disease|2018|30
Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms
|Scientific Reports|2019|22
Targeting glioma cells by antineoplastic activity of reversine
|Oncology Letters|2021|13